Valuation Phaarmasia Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:01:00 2026-07-15 EDT			5-day change	1st Jan Change
84.46 ^INR	-2.65%		-14.88%	-25.08%

05-29	Phaarmasia Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-15	Phaarmasia Limited Announces Change in the Registered Office Address Within the Local Limits	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	94.89	169.6	211.3	159.8	198.7	200.1
Change	-	78.78%	24.55%	-24.39%	24.36%	0.72%
Enterprise Value (EV) ¹	95.38	167.6	210.7	156.9	195.2	198.2
Change	-	75.7%	25.76%	-25.54%	24.42%	1.5%
P/E	17.6x	54.4x	-13.6x	-12.7x	-38.3x	-12.6x
PBR	0.71x	1.24x	1.75x	1.48x	1.93x	2.29x
PEG	-	-1.3x	0x	0.7x	0.7x	-0x
Capitalization / Revenue	0.39x	0.83x	1.23x	0.58x	0.65x	0.82x
EV / Revenue	0.39x	0.82x	1.22x	0.57x	0.64x	0.81x
EV / EBITDA	6.91x	20.5x	-16.6x	-13.6x	-63.3x	-15x
EV / EBIT	9.72x	35.3x	-13.5x	-11.2x	-36.6x	-12.1x
EV / FCF	-149x	25.3x	48.1x	10.7x	32.9x	47.9x
FCF Yield	-0.67%	3.95%	2.08%	9.36%	3.04%	2.09%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.79	0.457	-2.27	-1.844	-0.76	-2.33
Distribution rate	-	-	-	-	-	-
Net sales ¹	244.5	204.1	172.2	274.9	305.9	243.7
EBITDA ¹	13.8	8.165	-12.73	-11.51	-3.085	-13.19
EBIT ¹	9.813	4.753	-15.66	-14.05	-5.336	-16.39
Net income ¹	5.398	3.12	-15.47	-12.59	-5.182	-15.89
Net Debt ¹	0.481	-2.072	-0.5509	-2.841	-3.432	-1.937
Reference price ²	13.90	24.85	30.95	23.40	29.10	29.31
Nbr of stocks (in thousands)	6,827	6,827	6,827	6,827	6,827	6,827
Announcement Date	9/7/20	9/1/21	9/5/22	7/6/23	8/30/24	9/3/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PHAARMASIA LIMITED	-	-	-	-	6.17M
ELI LILLY AND COMPANY	34.25x	12.25x	25.43x	0.59%	1,028B
JOHNSON & JOHNSON	27.09x	6.22x	16.9x	2.1%	611B
ABBVIE INC.	30.33x	7.27x	14.9x	2.81%	432B
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	323B
NOVARTIS AG	21.17x	5.44x	13.17x	2.9%	277B
ASTRAZENECA PLC	20.69x	4.37x	12.08x	2.02%	257B
NOVO NORDISK A/S	13.99x	5.26x	10.84x	3.55%	217B
AMGEN INC.	23.3x	6.19x	10.94x	2.84%	192B
GILEAD SCIENCES, INC.	-46.85x	5.61x	31x	2.5%	161B
Average	15.72x	6.33x	16.22x	2.48%	349.83B
Weighted average by Cap.	23.34x	7.66x	17.88x	2.04%